Podcast: Perspectives and projections on the 2025 biotech landscape
The biotech landscape is undergoing rapid transformation, driven by a heightened emphasis on clinical-stage data and increasing demand for clinical trial services and faster deployment. At the same time, increased scrutiny has focused on US policies and regulations, as well as China’s expanding influence in biotech innovation. In this challenging environment we look at emerging market dynamics and what to expect in 2025.
